---
schema_version: '1.0'
id: government-20260724-5dbbee
content_kind: government-document
url: https://www.federalregister.gov/documents/2026/07/24/2026-15017/cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establishment-of-a-public
url_hash: 5dbbee0d1f22d960b4379d62b2a803861a8457980986e153645af246973d37d3
canonical_url: https://www.federalregister.gov/documents/2026/07/24/2026-15017/cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establishment-of-a-public
source: us-federal-register
category: government/us
category_raw: Notice
country: us
region: us
tags: []
lang: en
published_at: '2026-07-24T00:00:00Z'
fetched_at: '2026-07-24T09:01:24.941649Z'
updated_at: '2026-07-24T09:05:26Z'
status: published
content_hash: be7dfa5e023806ac06447ef0727101dbf5a985efb293ca82770e4b53b51952db
content_changed_at: null
license_note: full
license_basis: public-domain-17usc105
body_available: false
attribution: 'Source: Office of the Federal Register, National Archives and Records
  Administration'
license_rule: source:us-federal-register
summary: 'The Food and Drug Administration (FDA) is announcing an amendment to the
  notice of meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee
  (the Committee). This meeting was announced in the Federal Register on June 30,
  2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, and
  SUPPLEMENTARY INFORMATION: Procedure portion of the document. There are no other
  changes.'
summary_source: official
summary_en: 'The Food and Drug Administration (FDA) is announcing an amendment to
  the notice of meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee
  (the Committee). This meeting was announced in the Federal Register on June 30,
  2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, and
  SUPPLEMENTARY INFORMATION: Procedure portion of the document. There are no other
  changes.'
provenance:
  doc_id: 2026-15017
  doc_id_scheme: fr_docnum
  issuer:
  - Health and Human Services Department
  - Food and Drug Administration
  doc_type: Notice
  subtype: null
  action: Notice.
  significant: null
entities:
- name: Anderson Taylor
  type: person
- name: general_news
  type: category
key_facts: []
related: []
related_auto:
- name: Guinness World Records
  type: organization
  weight: 1.0
- name: bbc-china
  type: organization
  weight: 1.0
- name: China
  type: country
  weight: 1.0
- name: AI fears mount
  type: UNKNOWN
  weight: 1.0
- name: Czech Military Helicopter
  type: artifact
  weight: 1.0
title: Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting;
  Establishment of a Public Docket; Request for Comments-Biologics License Application
  (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec
---

# Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec

## TL;DR
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee (the Committee). This meeting was announced in the Federal Register on June 30, 2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, and SUPPLEMENTARY INFORMATION: Procedure portion of the document. There are no other changes.

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec](https://www.federalregister.gov/documents/2026/07/24/2026-15017/cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establishment-of-a-public) — published 2026-07-24T00:00:00Z